Hysterectomy (Surgical Resection)
Treatment for Uterine cancer
Typical Dosage: Surgical procedure
Effectiveness
90%
Safety Score
45%
Clinical Trials
41
Participants
1M
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
45
DangerousModerateSafe
Treatment Details
Dosage Range
Surgical procedure
Time to Effect
Immediate
Treatment Duration
One-time procedure, 4-8 weeks recovery
Evidence Quality
HIGHConfidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$10,000
Side Effect Mgmt:$1,500
Total Annual:$25,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
3.5
Outcome-Based Costs
Cost per Remission
$29,412
Hysterectomy (Surgical Resection) Outcomes
for Uterine cancer
Efficacy Outcomes
Overall Effectiveness
+90%
Remission Rate
+85%
Common Side Effects
Pain
+90%
Infection
+10%
Bleeding
+5%
Damage to adjacent organs
+2%
Deep vein thrombosis/Pulmonary embolism
+1%
Lymphedema (with lymphadenectomy)
+20%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
5 active trials recruiting for Hysterectomy (Surgical Resection) in Uterine cancer
Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
NCT06191133RECRUITINGPHASE1
24 participants
INTERVENTIONAL
Cleveland, United States
Started: Nov 20, 2024
Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy
NCT04494113ACTIVE NOT RECRUITINGEARLY_PHASE1
12 participants
INTERVENTIONAL
Coral Gables, United States +6 more
Started: Feb 8, 2022
Modified Tumor-free Techniques Operation to Cervical Cancer
NCT06836869RECRUITINGNA
524 participants
INTERVENTIONAL
Lanzhou, China +16 more
Started: Feb 20, 2025
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
NCT04934982RECRUITINGNA
690 participants
INTERVENTIONAL
Shanghai, China
Started: Sep 24, 2021
Robot-assisted Approach to Cervical Cancer
NCT03719547RECRUITINGNA
800 participants
INTERVENTIONAL
Stockholm, Sweden
Started: May 28, 2019
Completed Clinical Trials
5 completed trials for Hysterectomy (Surgical Resection) in Uterine cancer
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer
NCT00610740COMPLETEDPHASE2
18 participants
INTERVENTIONAL
Minneapolis, United States
Started: Jul 1, 2006
Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
NCT00002706COMPLETEDPHASE3
2.62K participants
INTERVENTIONAL
Philadelphia, United States
Started: Apr 1, 1996
Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer
NCT02562729COMPLETEDPHASE2
62 participants
INTERVENTIONAL
Shanghai, China
Started: Sep 1, 2015
Randomized Controlled Trial (RCT)Comparing GYNAECARE MORCELLEX Versus ROTOCUT GI Tissue Morcellators
NCT00743080COMPLETEDPHASE4
INTERVENTIONAL
Catanzaro, Italy
Started: Jan 1, 2008
Laparoscopic Approach to Cancer of the Endometrium
NCT00096408COMPLETEDPHASE3
760 participants
INTERVENTIONAL
Camperdown, Australia +22 more
Started: Oct 1, 2005
Showing 20 of 41 total trials